Hutchmed (13 HK) – A Fruitful 2024 on the Way_老虎社区_美港股上老虎

Hutchmed (13 HK) – A Fruitful 2024 on the Way

Smartkarma
2024-03-01

⬆ $Hutchmed China Ltd(00013)$ - Including US$312mn upfront and milestone payments from Takeda, HCM’s consolidated revenues from oncology/immunology reached US$529mn in FY23

Continue reading on Smartkarma:- https://www.smartkarma.com/insights/hutchmed-13-hk-a-fruitful-2024-on-the-way?utm_source=tiger_community

By CMB International, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cmb-international?utm_source=tiger_community

On Hutchmed China Ltd (00013):- https://www.smartkarma.com/entities/hutchmed-china-ltd?utm_source=tiger_community

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":279622638813200,"tweetId":"279622638813200","gmtCreate":1709298086600,"gmtModify":1709298347155,"author":{"id":4103332230805300,"idStr":"4103332230805300","authorId":4103332230805300,"authorIdStr":"4103332230805300","name":"Smartkarma","avatar":"https://static.tigerbbs.com/bb92df7ff435380d798b36afa44a5c07","vip":5,"userType":5,"introduction":"Smartkarma官方账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":339,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"Hutchmed (13 HK) – A Fruitful 2024 on the Way","html":"<html><head></head><body> \n⬆ $Hutchmed China Ltd(00013)$ - Including US$312mn upfront and milestone payments from Takeda, HCM’s consolidated revenues from oncology/immunology reached US$529mn in FY23\n \nContinue reading on Smartkarma:- https://www.smartkarma.com/insights/hutchmed-13-hk-a-fruitful-2024-on-the-way?utm_source=tiger_community\nBy CMB International, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cmb-international?utm_source=tiger_community\nOn Hutchmed China Ltd (00013):- https://www.smartkarma.com/entities/hutchmed-china-ltd?utm_source=tiger_community</body></html>","htmlText":"<html><head></head><body> \n⬆ $Hutchmed China Ltd(00013)$ - Including US$312mn upfront and milestone payments from Takeda, HCM’s consolidated revenues from oncology/immunology reached US$529mn in FY23\n \nContinue reading on Smartkarma:- https://www.smartkarma.com/insights/hutchmed-13-hk-a-fruitful-2024-on-the-way?utm_source=tiger_community\nBy CMB International, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cmb-international?utm_source=tiger_community\nOn Hutchmed China Ltd (00013):- https://www.smartkarma.com/entities/hutchmed-china-ltd?utm_source=tiger_community</body></html>","text":"⬆ $Hutchmed China Ltd(00013)$ - Including US$312mn upfront and milestone payments from Takeda, HCM’s consolidated revenues from oncology/immunology reached US$529mn in FY23 Continue reading on Smartkarma:- https://www.smartkarma.com/insights/hutchmed-13-hk-a-fruitful-2024-on-the-way?utm_source=tiger_community By CMB International, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cmb-international?utm_source=tiger_community On Hutchmed China Ltd (00013):- https://www.smartkarma.com/entities/hutchmed-china-ltd?utm_source=tiger_community","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/279622638813200","repostId":0,"isVote":1,"tweetType":1,"viewCount":27511,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["00013","HCM"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":520,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}